Women Stroke Association statement on stroke
Corresponding Author
Francesca Romana Pezzella
Stroke Unit – Department of Emergency Medicine, AO S Camillo Forlanini, Rome, Italy
Correspondence: Francesca Romana Pezzella*, Stroke Unit – Department of Emergency Medicine, AO S Camillo Forlanini, Piazza Carlo Forlanini 1, 00151 Rome, Italy.
E-mail: [email protected]
Search for more papers by this authorPaola Santalucia
Direzione Scientifica and U.O. Medicina d'Urgenza, Fondazione IRCCS Cà Granda, Ospedale Maggiore Policlinico, Milan, Italy
Search for more papers by this authorRita Vadalà
NeuroRadiology, IRCCS Fondazione S Lucia, Rome, Italy
Search for more papers by this authorElisabetta Giugni
Fondazione Biomedica Europea Onlus, Rome, Italy
Search for more papers by this authorMaria Luisa Zedde
Neurology Department, Arcispedale Santa Maria Nuova, Reggio nell'Emilia, Italy
Search for more papers by this authorMaria Sessa
Stroke Unit – Department of Neurology and Neurophysiology, San Raffaele Scientific Institute, Milan, Italy
Search for more papers by this authorSabrina Anticoli
Stroke Unit – Department of Emergency Medicine, AO S Camillo Forlanini, Rome, Italy
Search for more papers by this authorValeria Caso
Stroke Unit, University of Perugia, Santa Maria della Misericordia Hospital, Perugia, Italy
Search for more papers by this authorthe Women Stroke Association
Search for more papers by this authorCorresponding Author
Francesca Romana Pezzella
Stroke Unit – Department of Emergency Medicine, AO S Camillo Forlanini, Rome, Italy
Correspondence: Francesca Romana Pezzella*, Stroke Unit – Department of Emergency Medicine, AO S Camillo Forlanini, Piazza Carlo Forlanini 1, 00151 Rome, Italy.
E-mail: [email protected]
Search for more papers by this authorPaola Santalucia
Direzione Scientifica and U.O. Medicina d'Urgenza, Fondazione IRCCS Cà Granda, Ospedale Maggiore Policlinico, Milan, Italy
Search for more papers by this authorRita Vadalà
NeuroRadiology, IRCCS Fondazione S Lucia, Rome, Italy
Search for more papers by this authorElisabetta Giugni
Fondazione Biomedica Europea Onlus, Rome, Italy
Search for more papers by this authorMaria Luisa Zedde
Neurology Department, Arcispedale Santa Maria Nuova, Reggio nell'Emilia, Italy
Search for more papers by this authorMaria Sessa
Stroke Unit – Department of Neurology and Neurophysiology, San Raffaele Scientific Institute, Milan, Italy
Search for more papers by this authorSabrina Anticoli
Stroke Unit – Department of Emergency Medicine, AO S Camillo Forlanini, Rome, Italy
Search for more papers by this authorValeria Caso
Stroke Unit, University of Perugia, Santa Maria della Misericordia Hospital, Perugia, Italy
Search for more papers by this authorthe Women Stroke Association
Search for more papers by this authorAbstract
We describe the current and future objectives of the Women Stroke Association, a nonprofit multidisciplinary organization promoting research awareness on medical, psychological, and social issues concerning women affected by cerebro-cardiovascular disease. In this paper, we deal with only cerebrovascular disease, whereas cardiovascular disorders will be addressed in a future paper. Gender differences in the clinical presentation of cerebrovascular diseases have been repeatedly suggested, and some treatment options may not be as effective and safe in men and women. For many years, women have either been underrepresented or excluded from randomized clinical trials, and the majority of therapeutic research has been carried on predominantly male populations. Furthermore, gender differences have been shown to contribute to different responses to cerebrovascular drugs in women when compared with men, regarding pharmacokinetics, pharmacodynamics, and physiology. In this statement, we discuss main research fields relevant to Women Stroke Association's mission and commitment, highlighting opportunities and critical from the women's health perspective. Future directions and goals of the Women Stroke Association arise from these considerations and represent the association's commitment to combating stroke.
References
- 1 Reeves MJ, Bushnell CD, Howard G et al. Sex differences in stroke: epidemiology, clinical presentation, medical care, and outcomes. Lancet Neurol 2008; 7: 915–926.
- 2 Acciarresi M, Caso V, Venti M et al. First-ever stroke and outcome in patients admitted to Perugia Stroke Unit: predictors for death, dependency, and recurrence of stroke within the first three months. Clin Exp Hypertens 2006; 28: 287–294.
- 3 Caso V, Santalucia P, Acciarresi M, Pezzella FR, Paciaroni M. Antiplatelet treatment in primary and secondary stroke prevention in women. Eur J Intern Med 2012; 23: 580–585.
- 4 Santalucia P, Pezzella FR, Sessa M et al. Sex differences in clinical presentation, severity and outcome of stroke: results from a hospital-based registry. Eur J Intern Med 2013; 24: 167–171.
- 5 Caso V, Santalucia P, Pezzella FR. Depression and stroke risk. Womens Health (Lond Engl) 2012; 8: 35–37.
- 6 Appelros P, Stegmayr B, Terent A. Sex differences in stroke epidemiology: a systematic review. Stroke 2009; 40: 1082–1090.
- 7 Seshadri S, Beiser A, Kelly-Hayes M et al. The lifetime risk of stroke: estimates from the Framingham Study. Stroke 2006; 37: 345–350.
- 8 Kapral MK, Fang J, Hill MD et al. Sex differences in stroke care and outcomes: results from the Registry of the Canadian Stroke Network. Stroke 2005; 36: 809–814.
- 9 Reid JM, Dai D, Gubitz GJ, Kapral MK, Christian C, Phillips SJ. Gender differences in stroke examined in a 10-year cohort of patients admitted to a Canadian teaching hospital. Stroke 2008; 39: 1090–1095.
- 10 Stroebele N, Muller-Riemenschneider F, Nolte CH, Muller-Nordhorn J, Bockelbrink A, Willich SN. Knowledge of risk factors, and warning signs of stroke: a systematic review from a gender perspective. Int J Stroke 2011; 6: 60–66.
- 11 Truelsen T, Krarup LH. Stroke awareness in Denmark. Neuroepidemiology 2010; 35: 165–170.
- 12 Kautzky-Willer A, Dorner T, Jensby A, Rieder A. Women show a closer association between educational level and hypertension or diabetes mellitus than males: a secondary analysis from the Austrian HIS. BMC Public Health 2012; 12: 392.
- 13 Allais G, Gabellari IC, Mana O, Schiapparelli P, Terzi MG, Benedetto C. Migraine and stroke: the role of oral contraceptives. Neurol Sci 2008; 29(Suppl. 1): S12–14.
- 14 Baillargeon JP, McClish DK, Essah PA, Nestler JE. Association between the current use of low-dose oral contraceptives and cardiovascular arterial disease: a meta-analysis. J Clin Endocrinol Metab 2005; 90: 3863–3870.
- 15 Lidegaard O, Lokkegaard E, Jensen A, Skovlund CW, Keiding N. Thrombotic stroke and myocardial infarction with hormonal contraception. N Engl J Med 2012; 366: 2257–2266.
- 16 Bhat VM, Cole JW, Sorkin JD et al. Dose-response relationship between cigarette smoking and risk of ischemic stroke in young women. Stroke 2008; 39: 2439–2443.
- 17 Blickstein D, Blickstein I. Oral contraception and thrombophilia. Curr Opin Obstet Gynecol 2007; 19: 370–376.
- 18 Curtis KM, Mohllajee AP, Peterson HB. Use of combined oral contraceptives among women with migraine and nonmigrainous headaches: a systematic review. Contraception 2006; 73: 189–194.
- 19 Chang CL, Donaghy M, Poulter N. Migraine and stroke in young women: case-control study. The World Health Organisation Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. BMJ 1999; 318: 13–18.
- 20 Kittner SJ, Stern BJ, Feeser BR et al. Pregnancy and the risk of stroke. N Engl J Med 1996; 335: 768–774.
- 21 Salonen Ros H, Lichtenstein P, Bellocco R, Petersson G, Cnattingius S. Increased risks of circulatory diseases in late pregnancy and puerperium. Epidemiology 2001; 12: 456–460.
- 22 James AH, Bushnell CD, Jamison MG, Myers ER. Incidence and risk factors for stroke in pregnancy and the puerperium. Obstet Gynecol 2005; 106: 509–516.
- 23 Lanska DJ, Kryscio RJ. Risk factors for peripartum and postpartum stroke and intracranial venous thrombosis. Stroke 2000; 31: 1274–1282.
- 24 Meyers PM, Halbach VV, Malek AM et al. Endovascular treatment of cerebral artery aneurysms during pregnancy: report of three cases. AJNR Am J Neuroradiol 2000; 21: 1306–1311.
- 25 Davie CA, O'Brien P. Stroke and pregnancy. J Neurol Neurosurg Psychiatry 2008; 79: 240–245.
- 26 Sharshar T, Lamy C, Mas JL. Incidence and causes of strokes associated with pregnancy and puerperium. A study in public hospitals of Ile de France. Stroke in Pregnancy Study Group. Stroke 1995; 26: 930–936.
- 27 Bushnell CD, Jamison M, James AH. Migraines during pregnancy linked to stroke and vascular diseases: US population based case-control study. BMJ 2009; 338: b664.
- 28 Retnakaran R, Shah BR. Mild glucose intolerance in pregnancy and risk of cardiovascular disease: a population-based cohort study. CMAJ 2009; 181: 371–376.
- 29 Tzourio C, Iglesias S, Hubert JB et al. Migraine and risk of ischaemic stroke: a case-control study. BMJ 1993; 307: 289–292.
- 30 Kurth T, Slomke MA, Kase CS et al. Migraine, headache, and the risk of stroke in women: a prospective study. Neurology 2005; 64: 1020–1026.
- 31 Stang PE, Carson AP, Rose KM et al. Headache, cerebrovascular symptoms, and stroke: the Atherosclerosis Risk in Communities Study. Neurology 2005; 64: 1573–1577.
- 32 Kurth T, Kase CS, Schurks M, Tzourio C, Buring JE. Migraine and risk of haemorrhagic stroke in women: prospective cohort study. BMJ 2010; 341: c3659.
- 33 Bigal ME, Kurth T, Santanello N et al. Migraine and cardiovascular disease: a population-based study. Neurology 2010; 74: 628–635.
- 34 Schurks M, Rist PM, Bigal ME, Buring JE, Lipton RB, Kurth T. Migraine and cardiovascular disease: systematic review and meta-analysis. BMJ 2009; 339: b3914.
- 35 Kruit MC, van Buchem MA, Hofman PA et al. Migraine as a risk factor for subclinical brain lesions. JAMA 2004; 291: 427–434.
- 36 Sacco S, Cerone D, Carolei A. Comorbid neuropathologies in migraine: an update on cerebrovascular and cardiovascular aspects. J Headache Pain 2008; 9: 237–248.
- 37 Jesurum JT, Fuller CJ, Velez CA et al. Migraineurs with patent foramen ovale have larger right-to-left shunt despite similar atrial septal characteristics. J Headache Pain 2007; 8: 209–216.
- 38 Wilmshurst PT, Nightingale S, Walsh KP, Morrison WL. Effect on migraine of closure of cardiac right-to-left shunts to prevent recurrence of decompression illness or stroke or for haemodynamic reasons. Lancet 2000; 356: 1648–1651.
- 39 Dowson A, Mullen MJ, Peatfield R et al. Migraine Intervention With STARFlex Technology (MIST) trial: a prospective, multicenter, double-blind, sham-controlled trial to evaluate the effectiveness of patent foramen ovale closure with STARFlex septal repair implant to resolve refractory migraine headache. Circulation 2008; 117: 1397–1404.
- 40 Fang MC, Singer DE, Chang Y et al. Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study. Circulation 2005; 112: 1687–1691.
- 41 Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA 2001; 285: 2864–2870.
- 42 Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest 2010; 137: 263–272.
- 43
Glader EL, Stegmayr B, Norrving B et al. Sex differences in management and outcome after stroke: a Swedish national perspective. Stroke 2003; 34: 1970–1975.
10.1161/01.STR.0000083534.81284.C5 Google Scholar
- 44 Roger VL, Go AS, Lloyd-Jones DM et al. Heart disease and stroke statistics – 2012 update: a report from the American Heart Association. Circulation 2012; 125: e2–e220.
- 45 Poisson SN, Johnston SC, Sidney S, Klingman JG, Nguyen-Huynh MN. Gender differences in treatment of severe carotid stenosis after transient ischemic attack. Stroke 2010; 41: 1891–1895.
- 46 Murphy NF, Simpson CR, MacIntyre K, McAlister FA, Chalmers J, McMurray JJ. Prevalence, incidence, primary care burden and medical treatment of angina in Scotland: age, sex and socioeconomic disparities: a population-based study. Heart 2006; 92: 1047–1054.
- 47 Melloni C, Berger JS, Wang TY et al. Representation of women in randomized clinical trials of cardiovascular disease prevention. Circ Cardiovasc Qual Outcomes 2010; 3: 135–142.
- 48 Goldstein LB, Bushnell CD, Adams RJ et al. Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011; 42: 517–584.
- 49 Gurm HS, Rajagopal V, Sachar R et al. Impact of diabetes mellitus on outcome of patients undergoing carotid artery stenting: insights from a single center registry. Catheter Cardiovasc Interv 2007; 69: 541–545.
- 50 Mosca L, Benjamin EJ, Berra K et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women – 2011 update: a guideline from the American Heart Association. J Am Coll Cardiol 2011; 57: 1404–1423.
- 51 Wexler DJ, Grant RW, Meigs JB, Nathan DM, Cagliero E. Sex disparities in treatment of cardiac risk factors in patients with type 2 diabetes. Diabetes Care 2005; 28: 514–520.
- 52 Turner RC, Millns H, Neil HA et al. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23). BMJ 1998; 316: 823–828.
- 53 Gerstein HC, Miller ME, Byington RP et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008; 358: 2545–2559.
- 54 Kengne AP, Patel A, Colagiuri S et al. The Framingham and UK Prospective Diabetes Study (UKPDS) risk equations do not reliably estimate the probability of cardiovascular events in a large ethnically diverse sample of patients with diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron-MR Controlled Evaluation (ADVANCE) Study. Diabetologia 2010; 53: 821–831.
- 55 Hulley S, Grady D, Bush T et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA 1998; 280: 605–613.
- 56 Viscoli CM, Brass LM, Kernan WN, Sarrel PM, Suissa S, Horwitz RI. Estrogen therapy and risk of cognitive decline: results from the Women's Estrogen for Stroke Trial (WEST). Am J Obstet Gynecol 2005; 192: 387–393.
- 57 Wassertheil-Smoller S, Hendrix SL, Limacher M et al. Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial. JAMA 2003; 289: 2673–2684.
- 58 Turtzo LC, McCullough LD. Sex differences in stroke. Cerebrovasc Dis 2008; 26: 462–474.
- 59 Rocca WA, Shuster LT, Brown RD. Could estrogen protect younger menopausal women from stroke? Expert Rev Neurother 2012; 12: 363–365.
- 60 Harman SM, Brinton EA, Cedars M et al. KEEPS: the Kronos early estrogen prevention study. Climacteric 2005; 8: 3–12.
- 61 Hall S, Barr W, Lie JT, Stanson AW, Kazmier FJ, Hunder GG. Takayasu arteritis. A study of 32 North American patients. Medicine (Baltimore) 1985; 64: 89–99.
- 62 Mateen FJ, Zubkov AY, Muralidharan R et al. Susac syndrome: clinical characteristics and treatment in 29 new cases. Eur J Neurol 2012; 19: 800–811.
- 63 Mascarenhas R, Santo G, Goncalo M, Ferro MA, Tellechea O, Figueiredo A. Familial Sneddon's syndrome. Eur J Dermatol 2003; 13: 283–287.
- 64 Calabrese LH, Dodick DW, Schwedt TJ, Singhal AB. Narrative review: reversible cerebral vasoconstriction syndromes. Ann Intern Med 2007; 146: 34–44.
- 65 Ducros A, Fiedler U, Porcher R, Boukobza M, Stapf C, Bousser MG. Hemorrhagic manifestations of reversible cerebral vasoconstriction syndrome: frequency, features, and risk factors. Stroke 2010; 41: 2505–2511.
- 66 Reeves MJ, Wilkins T, Lisabeth LD, Schwamm LH. Thrombolysis treatment for acute stroke: issues of efficacy and utilization in women. Womens Health (Lond Engl) 2011; 7: 383–390.
- 67 Di Carlo A, Lamassa M, Baldereschi M et al. Sex differences in the clinical presentation, resource use, and 3-month outcome of acute stroke in Europe: data from a multicenter multinational hospital-based registry. Stroke 2003; 34: 1114–1119.
- 68 Smith MA, Lisabeth LD, Brown DL, Morgenstern LB. Gender comparisons of diagnostic evaluation for ischemic stroke patients. Neurology 2005; 65: 855–858.
- 69 Kelly AG, Hellkamp AS, Olson D, Smith EE, Schwamm LH. Predictors of rapid brain imaging in acute stroke: analysis of the get with the guidelines-stroke program. Stroke 2012; 43: 1279–1284.
- 70 Savitz SI, Schlaug G, Caplan L, Selim M. Arterial occlusive lesions recanalize more frequently in women than in men after intravenous tissue plasminogen activator administration for acute stroke. Stroke 2005; 36: 1447–1451.
- 71 Arnold M, Fischer U, Compter A et al. Acute basilar artery occlusion in the Basilar Artery International Cooperation Study: does gender matter? Stroke 2010; 41: 2693–2696.
- 72 Shah SH, Liebeskind DS, Saver JL et al. Influence of gender on outcomes after intra-arterial thrombolysis for acute ischemic stroke. Neurology 2006; 66: 1745–1746.
- 73 Forster A, Gass A, Kern R et al. Gender differences in acute ischemic stroke: etiology, stroke patterns and response to thrombolysis. Stroke 2009; 40: 2428–2432.
- 74 Hill MD, Kent DM, Hinchey J et al. Sex-based differences in the effect of intra-arterial treatment of stroke: analysis of the PROACT-2 study. Stroke 2006; 37: 2322–2325.
- 75 Ridker PM, Cook NR, Lee IM et al. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med 2005; 352: 1293–1304.
- 76 Berger JS, Roncaglioni MC, Avanzini F, Pangrazzi I, Tognoni G, Brown DL. Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials. JAMA 2006; 295: 306–313.
- 77 Baigent C, Blackwell L, Collins R et al. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet 2009; 373: 1849–1860.
- 78 Rothwell PM, Eliasziw M, Gutnikov SA, Warlow CP, Barnett HJ. Sex difference in the effect of time from symptoms to surgery on benefit from carotid endarterectomy for transient ischemic attack and nondisabling stroke. Stroke 2004; 35: 2855–2861.
- 79 Hellings WE, Pasterkamp G, Verhoeven BA et al. Gender-associated differences in plaque phenotype of patients undergoing carotid endarterectomy. J Vasc Surg 2007; 45: 289–296; discussion 96–7.
- 80 Alamowitch S, Eliasziw M, Barnett HJ. The risk and benefit of endarterectomy in women with symptomatic internal carotid artery disease. Stroke 2005; 36: 27–31.
- 81 Stingele R, Berger J, Alfke K et al. Clinical and angiographic risk factors for stroke and death within 30 days after carotid endarterectomy and stent-protected angioplasty: a subanalysis of the SPACE study. Lancet Neurol 2008; 7: 216–222.
- 82 Bonati LH, Dobson J, Algra A et al. Short-term outcome after stenting versus endarterectomy for symptomatic carotid stenosis: a preplanned meta-analysis of individual patient data. Lancet 2010; 376: 1062–1073.
- 83 Howard VJ, Lutsep HL, Mackey A et al. Influence of sex on outcomes of stenting versus endarterectomy: a subgroup analysis of the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST). Lancet Neurol 2011; 10: 530–537.
- 84 Endarterectomy for asymptomatic carotid artery stenosis. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. JAMA 1995; 273: 1421–1428.
- 85 Halliday A, Mansfield A, Marro J et al. Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial. Lancet 2004; 363: 1491–1502.
- 86 Halliday A, Harrison M, Hayter E et al. 10-year stroke prevention after successful carotid endarterectomy for asymptomatic stenosis (ACST-1): a multicentre randomised trial. Lancet 2010; 376: 1074–1084.
- 87 Gall SL, Donnan G, Dewey HM et al. Sex differences in presentation, severity, and management of stroke in a population-based study. Neurology 2010; 74: 975–981.
- 88 Wiszniewska M, Niewada M, Czlonkowska A. Sex differences in risk factor distribution, severity, and outcome of ischemic stroke. Acta Clin Croat 2011; 50: 21–28.
- 89
Gargano JW, Wehner S, Reeves M. Sex differences in acute stroke care in a statewide stroke registry. Stroke 2008; 39: 24–29.
10.1161/STROKEAHA.107.493262 Google Scholar
- 90 Gray LJ, Sprigg N, Bath PM et al. Sex differences in quality of life in stroke survivors: data from the Tinzaparin in Acute Ischaemic Stroke Trial (TAIST). Stroke 2007; 38: 2960–2964.
- 91 Cheung RT. Sexual functioning in Chinese stroke patients with mild or no disability. Cerebrovasc Dis 2002; 14: 122–128.